Terms: = Lung cancer AND PPM1D, Wip1, 8493, ENSG00000170836, O15297, WIP1, PP2C-DELTA
19 results:
1. A Case Study on ppm1d and 9 Other Shared Germline Alterations in a Family.
Biswas S; Manekar S; Bakshi SR
Asian Pac J Cancer Prev; 2023 Jun; 24(6):2129-2134. PubMed ID: 37378944
[TBL] [Abstract] [Full Text] [Related]
2. Clonal Hematopoiesis of Indeterminate Potential Predicts Adverse Outcomes in Patients With Atherosclerotic Cardiovascular Disease.
Gumuser ED; Schuermans A; Cho SMJ; Sporn ZA; Uddin MM; Paruchuri K; Nakao T; Yu Z; Haidermota S; Hornsby W; Weeks LD; Niroula A; Jaiswal S; Libby P; Ebert BL; Bick AG; Natarajan P; Honigberg MC
J Am Coll Cardiol; 2023 May; 81(20):1996-2009. PubMed ID: 37197843
[TBL] [Abstract] [Full Text] [Related]
3. Prevalence, causes and impact of TP53-loss phenocopying events in human tumors.
Fito-Lopez B; Salvadores M; Alvarez MM; Supek F
BMC Biol; 2023 Apr; 21(1):92. PubMed ID: 37095494
[TBL] [Abstract] [Full Text] [Related]
4. Nucleotide Excision Repair Pathway Activity Is Inhibited by Airborne Particulate Matter (PM
Quezada-Maldonado EM; Chirino YI; Gonsebatt ME; Morales-Bárcenas R; Sánchez-Pérez Y; García-Cuellar CM
Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216341
[TBL] [Abstract] [Full Text] [Related]
5. Targeting Squalene Epoxidase Interrupts Homologous Recombination via the ER Stress Response and Promotes Radiotherapy Efficacy.
Hong Z; Liu T; Wan L; Fa P; Kumar P; Cao Y; Prasad CB; Qiu Z; Liu J; Wang H; Li Z; Wang QE; Guo P; Guo D; Yilmaz AS; Lu L; Papandreou I; Jacob NK; Yan C; Zhang X; She QB; Ma Z; Zhang J
Cancer Res; 2022 Apr; 82(7):1298-1312. PubMed ID: 35045984
[TBL] [Abstract] [Full Text] [Related]
6. Inhibition of the DNA damage response phosphatase ppm1d reprograms neutrophils to enhance anti-tumor immune responses.
Uyanik B; Goloudina AR; Akbarali A; Grigorash BB; Petukhov AV; Singhal S; Eruslanov E; Chaloyard J; Lagorgette L; Hadi T; Baidyuk EV; Sakai H; Tessarollo L; Ryffel B; Mazur SJ; Lirussi F; Garrido C; Appella E; Demidov ON
Nat Commun; 2021 Jun; 12(1):3622. PubMed ID: 34131120
[TBL] [Abstract] [Full Text] [Related]
7. wip1 promotes cancer stem cell properties by inhibiting p38 MAPK in NSCLC.
Deng K; Liu L; Tan X; Zhang Z; Li J; Ou Y; Wang X; Yang S; Xiang R; Sun P
Signal Transduct Target Ther; 2020 Apr; 5(1):36. PubMed ID: 32296033
[TBL] [Abstract] [Full Text] [Related]
8. Clinical significance of wip1 overexpression and its association with the p38MAPK/p53/p16 pathway in NSCLC.
Yang S; Dong S; Qu X; Zhong X; Zhang Q
Mol Med Rep; 2017 Feb; 15(2):719-723. PubMed ID: 27959454
[TBL] [Abstract] [Full Text] [Related]
9. Truncating and missense ppm1d mutations in early-onset and/or familial/hereditary prostate cancer patients.
Cardoso M; Paulo P; Maia S; Teixeira MR
Genes Chromosomes Cancer; 2016 Dec; 55(12):954-961. PubMed ID: 27401275
[TBL] [Abstract] [Full Text] [Related]
10. Somatic Mosaic Mutations in ppm1d and TP53 in the Blood of Women With Ovarian Carcinoma.
Swisher EM; Harrell MI; Norquist BM; Walsh T; Brady M; Lee M; Hershberg R; Kalli KR; Lankes H; Konnick EQ; Pritchard CC; Monk BJ; Chan JK; Burger R; Kaufmann SH; Birrer MJ
JAMA Oncol; 2016 Mar; 2(3):370-2. PubMed ID: 26847329
[TBL] [Abstract] [Full Text] [Related]
11. Truncating mutations of ppm1d are found in blood DNA samples of lung cancer patients.
Zajkowicz A; Butkiewicz D; Drosik A; Giglok M; Suwiński R; Rusin M
Br J Cancer; 2015 Mar; 112(6):1114-20. PubMed ID: 25742468
[TBL] [Abstract] [Full Text] [Related]
12. Immunohistochemistry-based prognostic biomarkers in NSCLC: novel findings on the road to clinical use?
Lindskog C; Edlund K; Mattsson JS; Micke P
Expert Rev Mol Diagn; 2015 Apr; 15(4):471-90. PubMed ID: 25599124
[TBL] [Abstract] [Full Text] [Related]
13. ppm1d overexpression predicts poor prognosis in non-small cell lung cancer.
Yang H; Gao XY; Li P; Jiang TS
Tumour Biol; 2015 Mar; 36(3):2179-84. PubMed ID: 25412952
[TBL] [Abstract] [Full Text] [Related]
14. ppm1d silencing by RNA interference inhibits the proliferation of lung cancer cells.
Zhang C; Chen Y; Wang M; Chen X; Li Y; Song E; Liu X; Kim S; Peng H
World J Surg Oncol; 2014 Aug; 12():258. PubMed ID: 25123458
[TBL] [Abstract] [Full Text] [Related]
15. miR-15b/16-2 regulates factors that promote p53 phosphorylation and augments the DNA damage response following radiation in the lung.
Rahman M; Lovat F; Romano G; Calore F; Acunzo M; Bell EH; Nana-Sinkam P
J Biol Chem; 2014 Sep; 289(38):26406-26416. PubMed ID: 25092292
[TBL] [Abstract] [Full Text] [Related]
16. Proto-oncogene wip1, a member of a new family of proliferative genes in NSCLC and its clinical significance.
Fu Z; Sun G; Gu T
Tumour Biol; 2014 Apr; 35(4):2975-81. PubMed ID: 24272082
[TBL] [Abstract] [Full Text] [Related]
17. Bioinformatics analysis of two microarray gene-expression data sets to select lung adenocarcinoma marker genes.
Wu X; Zang W; Cui S; Wang M
Eur Rev Med Pharmacol Sci; 2012 Oct; 16(11):1582-7. PubMed ID: 23111975
[TBL] [Abstract] [Full Text] [Related]
18. p53-Independent expression of wild-type p53-induced phosphatase 1 (wip1) in methylmethane sulfonate-treated cancer cell lines and human tumors.
Park JY; Song JY; Kim HM; Han HS; Seol HS; Jang SJ; Choi J
Int J Biochem Cell Biol; 2012 Jun; 44(6):896-904. PubMed ID: 22405851
[TBL] [Abstract] [Full Text] [Related]
19. Oncogenic phosphatase wip1 is a novel prognostic marker for lung adenocarcinoma patient survival.
Satoh N; Maniwa Y; Bermudez VP; Nishimura K; Nishio W; Yoshimura M; Okita Y; Ohbayashi C; Hurwitz J; Hayashi Y
Cancer Sci; 2011 May; 102(5):1101-6. PubMed ID: 21281403
[TBL] [Abstract] [Full Text] [Related]
